Update on the management of postoperative nausea and vomiting

Current Opinion in Anaesthesiology

Volumn 27, Issue 6, 2014, Pages 605-609

  Skolnik, Aaron ^a   Gan, Tong J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antiemetic; Nausea; Postoperative nausea and vomiting; Prophylaxis; Vomiting

Indexed keywords

ANTIEMETIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DOPAMINE RECEPTOR BLOCKING AGENT; NEUROKININ 1 RECEPTOR ANTAGONIST; SEROTONIN ANTAGONIST;

ACUPUNCTURE; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); PATHOPHYSIOLOGY; PATIENT SATISFACTION; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC); TREATMENT INDICATION; DRUG COMBINATION; MULTIMODALITY CANCER THERAPY; PROCEDURES;

ACUPUNCTURE; ANTIEMETICS; CHOLINERGIC ANTAGONISTS; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; HUMANS; PATIENT SATISFACTION; POSTOPERATIVE NAUSEA AND VOMITING; RISK FACTORS; SEROTONIN ANTAGONISTS;

EID: 84927968206     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0000000000000128     Document Type: Review

References (32)

1. Gan TJ. Postoperative nausea and vomiting-can it be eliminated? JAMA 2002; 287:1233-1236.
2. Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004; 350:2441-2451.
3. Gold BS, Kitz DS, Lecky JH, et al. Unanticipated admission to the hospital following ambulatory surgery. JAMA 1989; 262:3003-3010.
4. Kovac A. Prevention and treatment of postoperative nausea and vomiting. Drugs 2000; 59:213-243.
5. Apfel CC, Laara E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999; 91:693-700.
6. Biedler A, Wermelt J, Kunitz O, et al. A risk adapted approach reduces the overall institutional incidence of postoperative nausea and vomiting. Can J Anaesth 2004; 51:13-19.
7. White PF, Sacan O, Nuangchamnong N, et al. The relationship between patient risk factors and early versus late postoperative emetic symptoms. Anesth Analg 2008; 107:459-463.
8. Kovac A. Update on the management of postoperative nausea and vomiting. Drugs 2013; 73:1525-1547.
9. Assaf RA, Clarke RS, Dundee JW, et al. Studies of drugs given before anesthesia. XXIV: metoclopramide with morphine and pethidine. Br J Anaesth 1974; 46:514-519.
10. Wallenborn J, Gelbrich G, Bulst D, et al. Prevention of postoperative nausea and vomiting by metoclopramide combined with dexamethasone: randomised double blind multicentre trial. BMJ 2006; 333:324.
11. Kranke P, Eberhart L, Motsch J, et al. I. V. APD421 (amisulpride) prevents postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled, multicentre trial. Br J Anaesth 2013; 111:938-945.
12. Rojas C, Stathis M, Thomas AG, et al. Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor. Anesth Analg 2008; 107:469-478.
13. Rojas C, Thomas AG, Alt J, et al. Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function. Eur J Pharmacol 2010; 626:193-199.
14. Candiotti KA, Kovac AL, Melson TI, et al. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting. Anesth Analg 2008; 107:445-451.
15. Chun HR, Jeon IS, Park SY, et al. Efficacy of palonosetron for the prevention of postoperative nausea and vomiting: a randomized, double-blinded, placebo-controlled trial. Br J Anaesth 2014; 112:485-490.
16. Laha B, Hazra A, Mallick S. Evaluation of antiemetic effect of intravenous palonosetron versus intravenous ondansetron in laparoscopic cholecystectomy: a randomized controlled trial. Indian J Pharmacol 2013; 45:24-29.
17. McCarthy BG, Peroutka SJ. Differentiation of muscarinic cholinergic receptor subtypes in human cortex and pons: implications for antimotion sickness therapy. Aviat Space Environ Med 1988; 59:63-66.
18. Apfel CC, Zhang K, George E, et al. Transdermal scopolamine for the prevention of postoperative nausea and vomiting: a systematic review and meta-analysis. Clin Ther 2010; 32:1987-2002.
19. Gan TJ, Sinha AC, Kovac AL, et al. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting. Anesth Analg 2009; 108:1498-1504.
20. Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2000; 90:186-194.
21. Wang JJ, Ho ST, Tzeng JI, et al. The effect of timing of dexamethasone administration on its efficacy as a prophylactic antiemetic for postoperative nausea and vomiting. Anesth Analg 2000; 91:136-139.
22. Karanicolas PJ, Smith SE, Kanbur B, et al. The impact of prophylactic dexamethasoneon nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis. Ann Surg 2008; 248:751-762.
23. Gan TJ, Meyer TA, Apfel CC, et al. Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2007; 105:1615-1628.
24. Mardani D, Bigdelian H. Prophylaxis of dexamethasone protects patients from further postoperative delirium after cardiac surgery: a randomized trial. J Res Med Sci 2013; 18:137-143.
25. Ali Khan S, McDonagh DL, Gan TJ. Wound complications with dexamethasone for postoperative nausea and vomiting prophylaxis: a moot point? Anesth Analg 2013; 116:966-968.
26. Apfel CC, Malhotra A, Leslie JB. The role of neurokinin-1 receptor antagonists for the management of postoperative nausea and vomiting. Curr Opin Anaesthesiol 2008; 21:427-432.
27. Gan TJ, Apfel CC, Kovac A, et al. A randomized, double-blind comparison of the NK1antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting. Anesth Analg 2007; 104:1082-1089.
28. Diemunsch P, Gan TJ, Philip BK, et al. Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind phase III trial in patients undergoing open abdominal surgery. Br J Anaesth 2007; 99:202-211.
29. Habib AS, Keifer JC, Borel CO, et al. A comparison of the combination of aprepitant and dexamethasone versus the combination of ondansetron and dexamethasone for the prevention of postoperative nausea and vomiting in patients undergoing craniotomy. Anesth Analg 2011; 112:813-818.
30. Gan TJ, Gu J, Singla N, et al. Rolapitant for the prevention of postoperative nausea and vomiting: a prospective, double-blinded, placebo-controlled randomized trial. Anesth Analg 2011; 112:804-812.
31. Singla NK, Singla SK, Chung F, et al. Phase II study to evaluate the safety and efficacy of the oral neurokinin-1 receptor antagonist casopitant (GW679769) administered with ondansetron for the prevention of postoperative and postdischarge nausea and vomiting in high-risk patients. Anesthesiology 2010; 113:74-82.
32. Lee A, Fan LT. Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev 2009; CD003281.